S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.10
+360.20
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.10
+62.50
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
CRVW · Careview Communications, Inc.
OTC MARKETS - Real Time Price • USD
$0.03
+0.00
(+0.00%)
● Overnight
DAY'S RANGE
$0.03
$0.03
$0.03
52-WEEK RANGE
$0.03
$0.01
$0.08
What's happening
- CRVW is up 0.00% today, trading at $0.03. — Live quote
- Reports earnings on 2026-11-10, 19 days away. (Finnhub earnings calendar)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
CRVW
+115.00%
vs S&P 500
+102.30%
1-YEAR RETURN
CRVW
+83.28%
vs S&P 500
+61.89%
6-MONTH RETURN
CRVW
+18.04%
3-MONTH RETURN
CRVW
-49.03%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-04-26 (Q1 2026)
$0.00
Est. $—
2026-01-26 (Q4 2025)
$-0.01
Est. $—
2025-10-26 (Q3 2025)
$0.00
Est. $—
2024-07-26 (Q2 2024)
$0.00
Est. $—
Valuation Measures & Ratios
Enterprise Value4$36.4M
Forward P/E5—
PEG Ratio6—
Price / Sales (TTM1)1.86
Price / Book773.43
EV4 / Revenue3.85
EV4 / EBITDA64.28
Profit Margin-28.94%
Operating Margin4.44%
Return on Equity (ROE8)-366.00%
Return on Assets (ROA9)-53.80%
Avg Volume (3M)49,380
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short204,224
Change from Prior Settlement+0.00%
% of Float—
Days to Cover (Short Ratio)24.30
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 19.6% on the provider's reported measure. Finnhub fundamentals ↗
- Trailing 52-week price return is +83.3%. Finnhub market metrics ↗
Potential concerns
- Net profit margin is -28.9%. Finnhub fundamentals ↗
- Latest SEC filing is Form 8-K, filed 2026-10-13; review it for current changes and risks. SEC EDGAR ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on CRVW
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.8M | $2.2M | $2.1M | $2.4M | $2.2M | $1.9M | $2.0M | $2.2M |
| Operating income | $507.0K | $30.8K | -$132.5K | $198.8K | -$134.7K | -$684.5K | -$319.1K | -$233.4K |
| Net income | -$283.7K | -$756.2K | -$914.2K | -$588.7K | -$920.8K | -$1.5M | -$1.1M | -$1.0M |
| EPS (diluted) | — | — | — | — | — | — | — | — |
| EPS (basic) | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating margin | $18 | $1 | -$6 | $8 | -$6 | -$35 | -$16 | -$11 |
| Net margin | -$10 | -$35 | -$44 | -$25 | -$41 | -$76 | -$56 | -$46 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $5.9M | $4.8M | $4.6M | $5.0M | $5.5M | $3.9M | $3.6M | $4.1M |
| Total liabilities | $49.6M | $48.4M | $47.7M | $47.4M | $47.2M | $45.1M | $44.1M | $43.6M |
| Stockholders' equity | -$43.8M | -$43.6M | -$43.0M | -$42.4M | -$41.6M | -$41.2M | -$40.4M | -$39.5M |
| Total current assets | $4.5M | $3.4M | $3.2M | $3.5M | $4.0M | $3.1M | $2.7M | $3.1M |
| Total current liabilities | $48.8M | $47.5M | $46.7M | $46.3M | $46.2M | $44.7M | $43.8M | $43.4M |
| Cash & equivalents | $1.9M | $1.4M | $1.5M | $1.7M | $1.8M | $1.0M | $759.3K | $1.4M |
| Accounts receivable | $1.7M | $1.3M | $1.0M | $1.0M | $1.5M | $1.4M | $1.0M | $997.0K |
| Inventory | $542.9K | $523.0K | $402.8K | $425.6K | $364.4K | $383.4K | $418.1K | $317.3K |
| Other current assets | $327.5K | $166.7K | $234.6K | $314.7K | $347.3K | $215.3K | $484.3K | $368.2K |
| Property, plant & equipment | $101.3K | $96.1K | $102.0K | $113.5K | $126.6K | $148.0K | $176.1K | $191.0K |
| Intangible assets | $347.5K | $356.6K | $366.0K | $366.4K | $377.4K | $386.8K | $397.4K | $408.6K |
| Other non-current assets | $207.7K | $179.1K | $207.7K | $199.2K | $225.8K | $229.5K | $258.9K | $294.1K |
| Accounts payable | $362.5K | $337.0K | $314.7K | $254.1K | $326.6K | $375.0K | $470.2K | $427.2K |
| Accrued liabilities | — | — | — | — | — | — | — | — |
| Deferred revenue (current) | $2.8M | $2.4M | $2.4M | $2.8M | $3.3M | $2.8M | $2.4M | $2.7M |
| Short-term debt | — | — | — | — | — | — | — | — |
| Other current liabilities | $370.8K | $258.1K | $268.3K | $436.3K | $491.0K | $280.7K | $387.1K | $458.3K |
| Long-term debt | — | — | — | — | — | — | — | — |
| Other non-current liabilities | $0 | $0 | $3.4K | $8.6K | $13.7K | $18.9K | $254.6K | $287.1K |
| Common stock & paid-in capital | $583.9K | $583.9K | $583.9K | $583.9K | $583.9K | $583.9K | $583.9K | $583.9K |
| Retained earnings | -$216.8M | -$216.5M | -$215.8M | -$215.0M | -$214.1M | -$213.5M | -$212.6M | -$211.5M |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $529.8K | -$126.2K | -$228.1K | $25.5K | $739.9K | $267.9K | -$698.0K | -$356.4K |
| Investing cash flow | -$21.5K | -$9.3K | $43.7K | -$56.9K | -$3.3K | -$1.1K | $56.9K | $19.9K |
| Financing cash flow | — | — | $0 | $0 | $0 | $0 | $0 | -$2.2K |
| Free cash flow | $508.3K | -$135.4K | -$231.9K | $25.1K | $736.5K | $266.8K | -$707.5K | -$363.1K |
| Capital expenditures | $21.5K | $9.3K | $3.8K | $478 | $3.3K | $1.1K | $9.5K | $6.7K |
| Depreciation & amortization | — | — | — | — | — | — | — | — |
| Share-based compensation | $151.6K | $150.3K | — | $155.6K | $156.0K | $154.7K | — | $158.7K |
| Deferred income taxes | — | — | $0 | — | — | — | $0 | — |
| Change in accounts receivable | $416.4K | $303.1K | -$21.0K | -$466.7K | $71.6K | $443.0K | $3.7K | -$345.9K |
| Change in inventory | $20.0K | $120.2K | -$22.8K | $61.2K | -$19.0K | -$34.7K | $100.8K | $7.9K |
| Change in accounts payable | $25.5K | $22.3K | $60.6K | -$72.5K | -$48.5K | -$95.1K | $42.9K | -$8.9K |
| Debt issued | — | — | — | — | — | — | — | — |
| Debt repaid | — | — | $0 | $0 | $0 | $0 | $0 | $2.2K |
| Other financing activities | — | — | — | — | — | — | — | — |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $9.0M | $8.3M | $9.7M | $7.9M | $7.8M |
| Operating income | -$55.0K | -$1.6M | -$688.3K | -$1.3M | -$1.1M |
| Net income | -$3.2M | -$4.7M | -$4.0M | — | — |
| EPS (diluted) | — | — | $-0.01 | $-0.04 | $-0.07 |
| EPS (basic) | $-0.01 | $-0.01 | $-0.01 | $-0.04 | $-0.07 |
| Operating margin | -$1 | -$19 | -$7 | -$16 | -$15 |
| Net margin | -$35 | -$57 | -$41 | — | — |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $4.6M | $3.6M | $4.3M | $3.9M | $5.1M |
| Total liabilities | $47.7M | $44.1M | $40.5M | $80.6M | $117.8M |
| Stockholders' equity | -$43.0M | -$40.4M | -$36.3M | -$76.7M | -$112.7M |
| Total current assets | $3.2M | $2.7M | $2.9M | $1.8M | $2.2M |
| Total current liabilities | $46.7M | $43.8M | $40.2M | $66.1M | $89.3M |
| Cash & equivalents | $1.5M | $759.3K | $1.1M | $420.2K | $659.2K |
| Accounts receivable | $1.0M | $1.0M | $1.2M | $948.3K | $933.2K |
| Inventory | $402.8K | $418.1K | $294.4K | $301.4K | $349.2K |
| Other current assets | $234.6K | $484.3K | $335.1K | $71.0K | $235.5K |
| Property, plant & equipment | $102.0K | $176.1K | $317.6K | $642.6K | $1.1M |
| Intangible assets | $366.0K | $397.4K | $406.3K | — | — |
| Other non-current assets | $207.7K | $258.9K | $302.0K | $1.5M | $1.8M |
| Accounts payable | $314.7K | $470.2K | $598.1K | $650.8K | $414.3K |
| Deferred revenue (current) | $2.4M | $2.4M | $1.8M | $890.6K | — |
| Short-term debt | — | — | $20.0M | $20.0M | $20.0M |
| Other current liabilities | $268.3K | $387.1K | $489.5K | $392.0K | $11.7M |
| Long-term debt | — | — | — | — | — |
| Other non-current liabilities | $3.4K | $254.6K | $178.9K | $23.5K | $37.6K |
| Common stock & paid-in capital | $583.9K | $583.9K | $583.9K | $141.9K | $139.4K |
| Retained earnings | -$215.8M | -$212.6M | -$207.9M | -$203.9M | -$197.9M |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | $805.2K | -$305.0K | $703.6K | -$370.1K | $678.8K |
| Investing cash flow | -$17.6K | -$73.5K | -$62.5K | -$5.2K | -$227.5K |
| Financing cash flow | $0 | -$8.0K | -$15.4K | $236.2K | -$150.0K |
| Free cash flow | $796.5K | -$351.1K | $686.8K | -$375.3K | $579.5K |
| Capital expenditures | $8.7K | $46.1K | $16.8K | $5.2K | $99.2K |
| Depreciation & amortization | — | — | $334.7K | $501.5K | $578.7K |
| Share-based compensation | — | — | $150.3K | $230.1K | $223.0K |
| Deferred income taxes | $0 | $0 | $0 | — | — |
| Change in accounts receivable | $26.9K | -$167.2K | $219.6K | $15.1K | -$213.3K |
| Change in inventory | -$15.4K | $123.7K | -$7.0K | -$47.8K | -$59.2K |
| Change in accounts payable | -$155.5K | -$127.9K | -$50.6K | $236.5K | -$27.7K |
| Debt issued | — | — | — | — | — |
| Debt repaid | $0 | $8.0K | $15.4K | — | — |
| Other financing activities | — | — | — | $250.0K | — |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding CRVW as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2023-03-30 to 2023-05-24
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)0 sh(0 txns)
Net Shares+0
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| HealthCor Management, L.P. | Director | Derivative conversion | 2023-05-24 | 86,515,000 |
| HealthCor Associates, LLC | Director | Derivative conversion | 2023-05-24 | 86,515,000 |
| Johnson Steven G. | President/CEO | Option exercise | 2023-03-30 | 17,500,000 |
| McRee Sandra K | Chief Operating Officer | Option exercise | 2023-03-30 | 1,000,000 |
| Lightcap Jeffrey C | Director | Option exercise | 2023-03-30 | 6,500,000 |
| Thompson Jason T | Director | Option exercise | 2023-03-30 | 1,500,000 |
| Wheeler L. Allen | Director | Option exercise | 2023-03-30 | 800,000 |
| HIGGINS JAMES R | Director | Option exercise | 2023-03-30 | 12,000,000 |
| EPSTEIN STEVEN B | Director | Option exercise | 2023-03-30 | 1,500,000 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 07:11 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-10-13 | 8-K | 2026-10-07 | View on SEC.gov → |
| 2026-10-06 | 8-K | 2026-09-30 | View on SEC.gov → |
| 2026-08-12 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-07-02 | 8-K | 2026-06-30 | View on SEC.gov → |
| 2026-05-13 | 10-Q | 2026-03-31 | View on SEC.gov → |
| 2026-04-02 | 8-K | 2026-03-30 | View on SEC.gov → |
| 2026-03-30 | 10-K | 2025-12-31 | View on SEC.gov → |
| 2026-01-06 | 8-K | 2025-12-31 | View on SEC.gov → |
| 2025-11-13 | 10-Q | 2025-09-30 | View on SEC.gov → |
| 2025-10-02 | 8-K | 2025-09-30 | View on SEC.gov → |
| 2025-08-13 | 10-Q | 2025-06-30 | View on SEC.gov → |
| 2025-07-02 | 8-K | 2025-06-30 | View on SEC.gov → |
Recent news
Headlines about CRVW (Careview Communications, Inc.). Links open the publisher — we don’t host full articles.
-
CareView Communications Expands Presence with North Las Vegas VA Medical Center
Yahoo · 2026-10-20 -
CoreWeave (CRVW) Shares Extend Decline Amid Debt Concerns; Canto
GuruFocus · 2026-10-16 -
CareView Communications Announces New VA Business Agreements, Expands Relationship in VA
Yahoo · 2026-10-13 -
CareView Communications Announces New Contract with Care New England
Yahoo · 2026-10-08 -
CareView Communications expands partnership with Northeast Georgia Medical Center - Braselton
Seeking Alpha · 2025-07-16 -
Careview Communications Is A Terminal Short
Seeking Alpha · 2012-08-21 -
CoreWeave, Inc. (CRWV) Stock Price, News, Quote & History
Yahoo! Finance Canada · 2026-10-21
No headlines in this category right now — try “All”.